Johnson & Johnson Faces Heat From RFK Jr. Over Sunscreen Claims

Robert F. Kennedy Jr. has accused Johnson & Johnson (J&J) of adding cancer-causing carcinogens to its sunscreens while profiting from treating those same cancers. The claim isn’t without basis. In 2021, J&J recalled five Neutrogena and Aveeno aerosol sunscreens after benzene—a carcinogen tied to leukemia—was detected in samples, following tests by Valisure that prompted an FDA investigation. J&J called the levels safe but pulled the products anyway, admitting a cancer-linked chemical made it into a skin-protection staple.

Meanwhile, J&J rakes in billions from cancer drugs like Imbruvica and Darzalex, which treat blood cancers potentially connected to benzene exposure. In 2023, these drugs earned over $3 billion and $9 billion, respectively. Add in J&J’s legal woes—thousands of lawsuits claiming asbestos in its talc caused cancer—and a pattern emerges.

Kennedy’s charge that J&J profits on both ends holds weight, even if benzene was a manufacturing slip, not a deliberate act. It’s a damning narrative with real-world roots.